comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemia
Not Applicable
- Conditions
- dyslipidemia
- Registration Number
- JPRN-UMIN000004944
- Lead Sponsor
- niversity of Fukui Faculty of Medical Sciences, Division of cardiovascular Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1,pregnant, breast feeding, or could be pregnant 2,severe liver diseases 3,severe kidney diseases (eGFR<30 mL/min/1.73m2) 4,history of allergic reaction to Pitavastatin or EPA 5,Physician does not agree to join the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method comparison of changes of LOX-1 ligand density and MT1-MMP expression rate
- Secondary Outcome Measures
Name Time Method comparison of change or %change of TC, TG, HDL-C, LDL-C, hs-CRP, sLOX-1 density and the fatty acid compartment